Skip to main content
. 2018 Jul 27;14(10):1343–1360. doi: 10.7150/ijbs.26111

Table 3.

Mode of action and therapeutic application of endogenous/biological and exogenous/biological NSPs inhibitors.

Inhibitor Origin Action Therapeutic use References
AAT endogenous/biological - anti-oxidant and anti- protease ARDS 21
Elafin endogenous/biological - lung tissue destruction protection ARDS 68, 69
- biomarker for monitoring early development of ARDS
SLPI endogenous/biological - inhibition of neutrophil phagocytosis
- protection of tissue damage by proteolytic enzymes
- inhibition of NFkB
COPD, ARDS [53, 66, 68,
70, 104]
- regulation of granulopoiesis
- inhibitor of apoptosis of circulating neutrophils
- inhibition of neutrophil phagocytosis
SerpinB1 endogenous/biological - inhibition of apoptosis of circulating neutrophils CF 53, 72, 73
- inhibition of CG
- promotion of PMN survival
inflammatory and autoimmune diseases
- control of neutrophil expontaneous death in PR3 deficient mice
Lactoferrin exogenous/biological - inhibition of NET formation and prevention of NET spread inflammatory and autoimmune diseases 97
Transhinone IIA exogenous/biological - block of pro-inflammatory signals in vivo 103
- inhibition of survival signals in human neutrophils
- modulation of neutrophil reverse migration
MDSPI16 (Musca domestica) exogenous/biological - inhibition of elastase, chymotrypsin, and microbial serine proteases 93
AvCI (Araneus ventricosus) exogenous/biological - inhibition of human NE and porcine pancreatic elastase
- block potassium channel activity
94
Triterpenoids (Ganoderma mastoporum) exogenous/ biological - inhibition of superoxide anion generation and elastase release inflammatory diseases 96

AAT: alfa1-anti-tripsin; ARDS: acute respiratory distress syndrome CF: cystic fibrosis; CG: cathepsin G; COPD: chronic obstructive pulmonary disease; NE: neutrophil elastase; NET: neutrophil extracellular trap: Nf-kB: nuclear factor kappa-light-chain enhancer of activated B cells; NET: neutrophil extracellular trap; PMN: polymorphonuclear; PR3: proteinase 3; SLPI: secretory leucocyte protease inhibitor.